Heart Disease Community
ENHANCE trial does not prove lipid lowering agents fail the general pop...
About This Community:

This patient support community is for discussions relating to angina, angioplasty, arrhythmia, bypass surgery, cardiomyopathy, coronary artery disease, defibrillator, heart attack, heart disease, mitral valve, pacemaker, PAD, stenosis, and stress tests.

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

ENHANCE trial does not prove lipid lowering agents fail the general population

Could you please comment on why the FDA has not issued an official advisory, but media is hyping and misleading the public regarding results from the ENHANCE trial (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia).  Merck and Schering-Plough submitted this for presentation as an pre-publication abstract at the American College of Cardiology meeting in March 2008.

Can you confirm these that I could dig up:

    * No difference between patients treated with ezetimibe/simvastatin 10/80 mg (Vytorin) versus patients treated with simvastatin 80 mg alone, over a two year period, for the primary endpoint of the mean change in intima-media thickness (IMT) measured at three sites in the carotid arteries. Carotid ultrasound studies are seen as reliable surrogate markers and predictive of future cardiac events.  There was a NON-statistically significant difference in wall thickness (p=0.29).

    * The Heterozygous Familial Hypercholesterolemia (HFH) population studied had baseline LDL measurements > 300 mg/dL. These patients make up 0.2% of the general population and are NOT representative of the typical patient receiving medication for hyperlipidemia.

    * Since conclusive evidence of ezetimibe's true effect is not available until studies on the general population with more power are published, maximizing statin dosing whenever possible is warranted for many patients with hypercholesterolemia.  Niacin or colesevelam (Welchol) are  alternatives to consider for statin intolerant patients.

http://www.merck.com/newsroom/press_releases/product/2008_0114.html
Related Discussions
-7 Comments Post a Comment
Blank
21064_tn?1309312333
I'm thinking that you want to direct your questions to one of the cardiologists.  To the right, there are separate links for questions to the doctor(s) and questions/comments to the community at large.

Connie
Blank
242516_tn?1368227505
Oh!  darnit.  i don't think i can since there's no free questions left today.  shucks.
Blank
21064_tn?1309312333
Try the Interventional Cardiology board : )
Post a Comment
To
MedHelp Health Answers
Recent Activity
Avatar_m_tn
Blank
ill13632 severe disease Comment
Apr 14
1317224_tn?1378708734
Blank
MaryLL I'm feeling good 16 months ... Comment
Apr 13
1317224_tn?1378708734
Blank
MaryLL uploaded new photos
Apr 13
Blank
BloodPressure Tracker
Monitor Your Blood Pressure
Start Tracking Now
Heart Disease Community Resources
RSS Expert Activity
242532_tn?1269553979
Blank
Emotional Eaters: How to Silence Yo...
Mar 26 by Roger Gould, M.D.Blank
1344197_tn?1392822771
Blank
Vaginal vs. Laparoscopic Hysterecto...
Feb 19 by J. Kyle Mathews, MD, DVMBlank
1684282_tn?1350782543
Blank
The Death by Heroin
Feb 03 by Julia M Aharonov, DOBlank
Top Heart Disease Answerers
976897_tn?1379171202
Blank
ed34
watford, United Kingdom
63984_tn?1385441539
Blank
Flycaster305
97303, OR
159619_tn?1318997813
Blank
erijon
Salt Lake City, UT
Avatar_f_tn
Blank
skydnsr
212161_tn?1391090750
Blank
heartfluttersflyawayplz
hoschton, GA
612551_tn?1247839157
Blank
Jerry_NJ
NJ